ranolazine has been researched along with Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besson, P; Bon, E; Bougnoux, P; Chevalier, S; Collin, C; Driffort, V; Gillet, L; Joulin, V; Jourdan, ML; Le Guennec, JY; Marionneau-Lambot, S; Oullier, T; Pagès, JC; Roger, S | 1 |
1 other study(ies) available for ranolazine and Breast Cancer
| Article | Year |
|---|---|
Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization.
Topics: Acetanilides; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Female; Humans; Lung; Mice; Mice, Nude; NAV1.5 Voltage-Gated Sodium Channel; Neoplasm Invasiveness; Neoplasm Metastasis; Piperazines; Ranolazine | 2014 |